These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Author: Ehmann TS, Delva NJ, Beninger RJ.
    Journal: J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328.
    Abstract:
    Two neuroleptics having different effects at dopamine receptors were administered to chronic schizophrenic inpatients to compare their therapeutic efficacy and ability to produce side effects. Haloperidol appeared to produce lower levels of psychopathology than flupenthixol but similar levels of side effects. No evidence was found that flupenthixol is specifically useful in "activating" chronic patients or in alleviating affective symptoms. Although these are preliminary results, they support the view that D2 receptors may mediate the antipsychotic effects of neuroleptic drugs.
    [Abstract] [Full Text] [Related] [New Search]